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Alkaline borohydride reductive cleavage (/l-elimination) of desialylated human K-caseinoglycopeptide re- 
sulted in the release of a series of oligosaccharides. The smaller-size compounds among them were purified 
to virtual homogeneity by gel filtration followed by high-performance liquid chromatography. The struc- 
tures of 9 oligosaccharides were determined by ‘H-NMR spectroscopy in conjunction with sugar analysis. 
The tetrasaccharide Galb( 1+3)[Galb( 1+4)GlcNA@( 1 +B)]GalNAc-ol and various partial structures there- 
of were characterized. Notably, the disaccharide GlcNAcB( 1+6)GalNAc-ol and the trisaccharide 
Gal& 1-+4)GlcNAcfi( 1+6)GalNAc-ol were identified; they represent a novel type of core structure for mu- 
tin-type carbohydrate chains, namely a peptide-linked GalNAc that is mono-substituted at C-6. In addition, 
some oligosaccharides ending in GlcNAc-01 could be characterized. Their possible origin is discussed. 
ic- Casein Carbohydrate moiety HPLC ‘H-NMR spectroscopy (Human) 
1. INTRODUCTION 
The casein complex involved in the milk-clotting 
process contains among several proteins only one 
glycoprotein, namely, x-casein. During the 
primary phase of this process, para-x-casein is 
formed as an insoluble part, while a soluble frac- 
tion, x-caseinoglycopeptide (x-CGP) is released. 
The latter contains the complete carbohydrate 
moiety of x-casein [l]. Only one prosthetic sugar 
group was characterized in bovine x-casein from 
mature milk whereas two such groups were iden- 
tified in bovine colostrum [2]. The sugar part was 
found to be microheterogeneous; the structures of 
3 oligosaccharides from bovine mature milk X- 
casein have been established in the P-eliminative 
Abbreviations: x-CGP, x-caseinoglycopeptide; HPLC, 
high-performance liquid chromatography 
cleavage product [3,4], namely, NeuAccr(2-t 3)- 
GaW(l --) 3)GalNAc - 01, Gav(l + 3)[NeuAccu - 
(2+ 6)]GalNAc-ol and NeuAw(2 + 3)Gal,&( 1-+ 3)- 
[NeuAccr(2+6)]GalNAc-01. In x-casein from cow 
colostrum, 6 oligosaccharides could be character- 
ized possessing GlcNAc as typical extra constituent 
[5-81. 
In human x-CGP the presence of several (up to 
10) prosthetic sugar groups has been demonstrated 
[9]. All the sugar-peptide linkages are O- 
glycosidic. The carbohydrate content of human X- 
CGP is around 55% whereas cow x-CGP contains 
only 10% sugar [9]. Not only Gal, GalNAc and 
NeuAc, but also Fuc and GlcNAc were identified 
as constituent monosaccharides. 
This paper deals with the preparation and the 
structural characterization of the smaller-size 
oligosaccharide-alditols i olated from desialylated 
human x-CGP after alkaline borohydride reduc- 
tive cleavage. 
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2. MATERIALS AND METHODS 
Casein from fresh, pooled human milk was 
prepared according to Alais and Jolles [lo]. 
Human K-CGP soluble in 12% trichloroacetic acid 
was obtained from the whole casein after chymosin 
digestion and chromatography on DEAE- 
Sephadex A-25 according to Fiat et al. [9]. Human 
K-CGP was digested successively by neuramini- 
dase, trypsin and pronase, filtered on Sephadex 
G-25 and finally chromatographed on DEAE- 
Sephadex A-25 according to [9]. 
After shortening of the peptide moieties, the K- 
CGP was treated with alkaline borohydride 
(0.05 M NaOH and 1.0 M NaBH4) for 16 h at 
50°C under nitrogen in the dark [ll]. After 
desalting on Dowex 50 W-X 2 (H+) with 2 mM for- 
mic acid as eluent and washing with methanol, the 
sugar moieties were isolated by filtration on Bio- 
Gel P-4 (250 x 0.9 cm) with water as eluent. Sugar- 
positive fractions, stained with the orcinol/sulfuric 
acid reagent, were further purified either by 
descending paper chromatography (Whatman 
no.1) for 18 h in the solvent system ethyl 
acetate/pyridine/water/acetic acid (5 : 5 : 3 : 1, by 
vol.) (for the oligosaccharides obtained from short 
glycopeptides) or by HPLC (for those obtained 
directly from asialo x-CGP). 
HPLC of the oligosaccharides was conducted on 
a Waters chromatograph model ALC/GPC 204 
equipped with a MicroPak AX-5 column (30 x 
0.4 cm) (Varian). Elution was performed with a 
linear gradient of acetonitrile-water (85 : 15-60 : 
40, by vol.) for 90 min at room temperature and a 
flow rate of 1 ml/min. All solvents were degassed 
by sonication before application. Sugars were 
detected at 200 nm. 
Sugar analysis of the oligosaccharides was per- 
formed by gas-liquid chromatography after 
methanolysis and trimethylsilylation as in [ 121. ‘H- 
NMR spectroscopy of DzO solutions of the 
oligosaccharides was conducted at 500 MHz, using 
a Bruker WM-500 spectrometer (SON-NMR facili- 
ty, Nijmegen, The Netherlands). Further ex- 
perimental details have been described [S, 131. 
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Structure of 9 core oligosaccharides that were identified in the&elimination product of desialylated human 
x-caseinoglycopeptide 
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Fig. 1. Elution profile of filtration on Bio-Gel P-4 (250 x 
0.9 cm) of desialylated human x-caseinoglycopeptide 
reduced by alkaline borohydride treatment. Water was 
used as eluent. 
3. RESULTS 
Enzymic digestion of asialo human x-CGP af- 
forded two short glycopeptides designated la 
(amino acid residues 45-65) and 2 (residues 2 l-37) 
according to Fiat et al. [9]. These were submitted 
to alkaline borohydride treatment, filtration on 
Bio-Gel P-4 and paper chromatography. From 
glycopeptide 1 a, two major oligosaccharides, 
denoted A (Rw = 1.0) and B (RQI = 0.72), were 
purified. From glycopeptide 2, two oligosac- 
charides with virtually the same RGal values as A 
and B, namely, C (Z&I = 1 .O) and D (Real = 0.77) 
were obtained. The structures of A to D were 
established by 500 MHz ‘H-NMR spectroscopy 
(scheme 1). 
0.2 
Alternatively, desialylated human x-CGP 
(75 mg) was subjected, as such, to alkaline 
borohydride treatment, and subsequently passed 
over Bio-Gel P-4. Eight fractions were obtained 
(fig.1); 1 and 2 contained peptides, 7 and 8 con- 
tained just salts, but fractions 3-6 consisted of car- 
bohydrate material. The smaller-size P-4 fractions 
(5 and 6) were further fractionated by HPLC. The 
elution profiles were unexpectedly complex. Frac- 
tion 5 gave rise to 6 major peaks (denoted 5.1-5.6) 
(fig.2), and fraction 6 to 5 main peaks (6.1-6.5) 
(fig.3). The purity of each of these fractions was 
checked by rechromatography on HPLC. If 
necessary, a second preparative HPLC run was 
carried out. In table 1, we report the molar car- 
bohydrate composition of the various HPLC- 
separated oligosaccharide fractions. Tables 2 and 3 
list the ‘H-NMR characteristics of these fractions, 
acquired for D20 solutions at 500 MHz. 
Carbohydrate analysis revealed (table 1) that the 
HPLC-separated subfractions 5.1-5.6 and 
6.1-6.5 contained either GalNAc-ol or GlcNAc-01 
as the principal reduced monosaccharide. Only in 
fraction 6.2 were these monosaccharide-alditols 
both present in considerable amounts (see footnote 
to table 1). On the basis of the type of reduced 
monosaccharide, the remaining 10 oligo- 
saccharide-alditols were classified into two groups. 
The ‘H-NMR parameters of the compounds 
ending in GalNAc-ol (6.1, 6.3, 5.3-5.6) have been 
compiled in table 2, those of the GlcNAc-ol- 
containing ones (5.1, 5.2, 6.4 and 6.5) in table 3. 
Fractions 6.1, 6.3, 5.5 and 5.6 could be readily 
identified by combination of ‘H-NMR (table 2) 
!i3 
55 56 
20 30 40 60 60 IW” 
Fig.2. HPLC of Bio-Gel P-4 fraction 5 on a MicroPak AX-5 column (30 x 0.4 cm) (Varian). Elution conditions: a 
90-min linear gradient of 85 : 15-60:40 (v/v) acetonitrile/water. Absorption was detected at 200 nm. 
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Fig.3. HPLC of Bio-Gel P-4 fraction 6 on a MicroPak AX-5 column (30 x 0.4 cm) (Varian). Elution conditions: a 
90-min linear gradient of 85 : 15-60:40 (v/v) acetonitrile/water. Absorption was detected at 200 nm. 
and sugar analysis (table 1) as mono-, di-, tri- and 
tetrasaccharides with the structures GalNAc-ol, 
GalPU +3)GalNAc-01, Gal,&1 -+ 3)[GlcNAcp(l + 
6)1GalNAc-ol and Gal@( 1-+3)[Gal,B( 1+4)Glc- 
NAcP(1+6)]GalNAc-01, respectively. The ‘H- 
Table 1 
Molar carbohydrate composition of the HPLC- 
separated smaller-size oligosaccharide-alditols, derived 
from desialylated human x-caseinoglycopeptide 
HPLC Molar ratioa of monosaccharides 
fraction 
Gal GlcNAc GlcNAc-01 GalNAc-ol 
5.1b + - 1.0 _ 
5.2 - - 1.0 - 
5.3 0.1 0.8 + 1.0 
5.4 1.1 0.8 _ 1.0 
5.5 1.1 0.9 - 1.0 
5.6 2.1 0.9 _ 1.0 
6.1 - _ - 1.0 
6.2bC 0.2 - 4.0 1.0 
6.3 1.0 _ - 1.0 
6.4b 0.8 _ 1.0 + 
6.5 1.0 + 1.0 + 
a Molar ratios were calculated on the basis of one 
residue of either GalNAc-ol or GlcNAc-01 per 
molecule 
b Also contains Gal-01 in detectable amounts 
’ Found to be a mixture of two or three mono- 
saccharide-alditols 
+ , less than 0.1; - , not detectable at all 
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NMR features of each of these fractions match 
exactly those reported for the same compounds ob- 
tained from other sources [4,14,15]. 
The ‘H-NMR parameters of fractions 5.3 and 
5.4 had not been observed before. Carbohydrate 
analysis (table 1) suggests that a disaccharide and 
a trisaccharide are concerned, respectively, con- 
sisting of GlcNAc and GalNAc-ol(5.3) and of Gal, 
GlcNAc and GalNAc-ol (5.4). The type of linkage 
between GlcNAc and GalNAc-ol in 5.3 could be 
identified by ‘H-NMR spectroscopy as p(1-96). 
The substitution site at GalNAc-ol could be de- 
duced from the set of chemical shifts observed for 
GalNAc-ol H-2 and H-5 (S 4.24 and 6 4.02, re- 
spectively). These are similar to the values reported 
for the disaccharide NeuAm(2+6)GalNAc-ol [4], 
and therefore (cf. [16]) proposed to be character- 
istic of monosubstitution of GalNAc-ol at C-6. 
The &configuration of the linkage is evident from 
the chemical shift of GlcNAc H-l, in conjunction 
with its coupling constant (Jr,2 = 8.2 Hz). 
Compound 5.4 can be conceived as an extension 
of the 5.3 disaccharide by an additional Gal 
residue. The core type of 5.4 is the same as that of 
5.3, as is evident from the set of chemical shifts of 
GalNAc-ol H-2 and H-5 (see table 2). This implies, 
that the Gal residue must be attached to GlcNAc. 
From the chemical shift of Gal H-l (S 4.470, Jr.2 = 
7.8 Hz), as well as from the effect observed on 6 
H-l of GlcNAc (AS 0.022) and on NAc of GlcNAc 
(AS 0.002) upon comparison of 5.4 to 5.3, it can be 
concluded [13] that the linkage between Gal and 
GlcNAc is ,&l-+4). 
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Fig.4. 500 MHz ‘H-NMR spectrum (DzO, 27°C) of HPLC-fraction 5.4, obtained from human x-caseinoglycopeptide, 
containing the linear trisaccharide-alditol with the indicated, novel structure. 
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Table 2 
Relevant ‘H-NMR characteristics of constituent monosaccharides for the smaller-size 
oligosaccharides derived from desialylated human x-caseinoglycopeptide, ending in 
GalNAc-ol 
Chemical shift” in 
Residueb 
0 
Reporter 
group 
6.1 6.3 5.3 5.4 5.5 5.6 
GalNAc-ol 
Gal3 
H-2 4.253 
H-3 3.848 
H-4 3.391 
H-5 3.929 
H-6 3.67 
NAc 2.057 
H-l _ 
H-2 - 
H-4 _ 
GlcNAc6 H-l _ 
H-6 _ 
NAc _ 
Gal4 H-l _ 
H-2 _ 
H-4 - 
4.392 4.243 4.243 4.392 4.392 
4.061 3.842 3.843 4.060 4.057 
3.506 3.382 3.379 3.467 3.463 
4.194 4.022 4.025 4.278 4.281 
3.69 3.93 3.932 3.933 3.930 
2.051 2.047 2.045 2.065 2.067 
4.476 _ _ 
3.564 - _ 
3.901 _ _ 
4.464 4.464 
3.542 3.538 
3.899 3.901 
4.555 4.577 4.537 4.559 
3.93 3.993 3.933 3.996 
2.059 2.061 2.065 2.064 
- 4.470 - 4.469 
_ 3.537 _ 3.540 
- 3.925 _ 3.924 
a Data were acquired at 500 MHz, for D20 solutions at 27°C. Chemical shifts are in 
ppm relative to DSS (internal acetone taken at 6 2.225 ppm) 
b A superscript at the name of a sugar residue indicates to which position of the 
adjacent monosaccharide it is linked 
(0) GalNAc-01, (e) Gal, (t ) GlcNAc 
The carbohydrate analyses (table 1) and ‘H- 
NMR features (table 3) of fractions 5.1, 5.2, 6.4 
and 6.5 reveal that the former two fractions con- 
tain merely GlcNAc-01, while the latter two con- 
tain disaccharides Gal-GlcNAc-01. From com- 
parison of the ‘H-NMR data of 6.4 and 6.5 with 
those published by Hounsell et al. for similar 
disaccharides [ 171, it could be readily concluded 
that 6.4 consists of Gal,&(1+3)GlcNAc-01 while 6.5 
is the isomer Gal,0(1+4)GlcNAc-01. In this 
respect, it should be noted that, in particular, the 
chemical shifts of H-2 of GlcNAc-01 (8 4.25 vs 6 
4.30) and NAc of GlcNAc-01 (S 2.034 vs 6 2.053) 
are of discriminative value. The structures of the 
HPLC-separated oligosaccharides from human x- 
CGP have been compiled in scheme 1. 
4. DISCUSSION 
The classical approach (cf. [3,4]) of isolation 
and purification of O-glycosidic oligosaccharides, 
that is, paper chromatography performed on the 
Bio-Gel P-4 fractionated p-elimination product 
of human x-CGP, afforded just two types of 
core structure, namely, Gal& 1 + 3)GalNAc 
-01 and Gal,8(1-+3)[Ga~(l+4)GlcNAc@(l+6)]- 
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Table 3 
Relevant ‘H-NMR characteristics of constituent 
monosaccharides for the smaller-size oligosaccharides 
derived from desialylated human x-caseinoglycopeptide, 
ending in GlcNAc-01 
Chemical shift” in 
Residue Reporter @ b b 
group 
5.1; 5.2 6.4 6.5 
GlcNAc-01 H-2 4.072 4.249 4.303 
H-3 3.956 4.166 n.d. 
H-5 3.748 n.d. n.d. 
H-6 3.816 3.842 n.d. 
NAc 2.043 2.034 2.053 
Gal3 H-l _ 4.498 
H-2 _ 3.565 
H-4 - 3.902 
Gal” H-l 
H-2 
H-4 
_ _ 
_ ACKNOWLEDGEMENTS 
4.499 
3.565 
3.910 
a Data were acquired at 500 MHz, for DzO solutions at 
27°C. Chemical shifts are expressed in ppm relative to 
DSS (internal acetone taken at 6 2.225 ppm) 
b A superscript at the name of a sugar residue indicates 
to which position of the adjacent monosaccharide it is 
glycosidically linked 
(0) GlcNAc-01, (B---) Gal; n.d., value could not be 
determined 
GalNAc-01. It is impressive to notice that combina- 
tion of HPLC (after Bio-Gel P-4 filtration) and 
‘H-NMR spectroscopy succeeded in elucidation of 
another 4 (although less abundant) types of core 
oligosaccharides. The structures resulting from the 
paper chromatographic working-up procedure 
were found again (6.3 and 5.6, see scheme 1). Also 
partial structures thereof, lacking the Gal&(1 ‘3) 
and/or Galp(l-+4) residues, respectively, were 
demonstrated to occur. In particular, the struc- 
tures 5.3 and 5.4 containing the 
GlcNAc& 1-+6)GalNAc-ol element draw the atten- 
tion, because this is a novel type of 0glycosidic 
core structure (the corresponding trisaccharide has 
been found to occur in human meconium [ 181). 
Moreover, the occurrence of this structure suggests 
that in human an alternative pathway for the 
biosynthesis of mucin-type chains exists; current 
views are that the GlcNAc,&( l-6) transferase does 
not recognize GalNAccu( 1 +O)Ser/Thr as a 
substrate, until GalNAc has been substituted at 
C-3 by a Gal or a GlcNAc residue [19,20]. 
In addition to the wanted&elimination products 
ending in GalNAc-01, a number of smaller-size 
oligosaccharides were found to end in GlcNAc-01. 
Regarding their origin, two possibilities have to be 
considered. Either, they stem from degradation 
(peeling reactions [21]) of regular GalNAc- 
containing chains, or they represent a rather 
uncommon sugar/peptide linkage, namely, 
GlcNAc(1 +O)Ser/Thr (cf. [22]). HPLC fractiona- 
tion and ‘H-NMR analysis of the larger oligosac- 
charides present in Bio-Gel P-4 fractions 3 and 4, 
may be helpful to shed more light on this aspect. 
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